Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.
2 registered trials, newest registry update first. Showing only trials linked to TB-500.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers NCT04555824 | TB-500 | Phase 1 | Completed | Beijing Northland Biotech. Co., Ltd. | 54 | Feb 20, 2018 | Sep 29, 2020 |
| A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers NCT04555850 | TB-500 | Phase 1 | Completed | Beijing Northland Biotech. Co., Ltd. | 30 | Feb 18, 2019 | Sep 29, 2020 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.
